READ FOR YOURSELF...don't listen to these bashers!
13:38 ATHN AthenaHealth issues downside FY12 EPS guidance and in line FY12 revs guidance; reaffirms FY11 guidance (52.46 -5.57) Co reaffirmed existing guidance for fiscal year 2011, most recently updated within the Company's Q3 2011 earnings release. Co also issues downside FY12 EPS guidance of $0.85-0.97, excluding non-recurring items, vs. $1.13 Capital IQ Consensus Estimate. Co issues In-Line FY12 revenue guidance of $410-430 mln vs. $421.80 mln Capital IQ Consensus Estimate. The guidance for FY12 includes Non-GAAP Adjusted Gross Margin of 61.5-62.5% (FY11 was 62.4%)... "We remain confident in achieving our stated goals for fiscal year 2011 and are pleased to present an ambitious plan for fiscal year 2012...Our fiscal year 2012 expectations are consistent with our long-standing goals to grow revenue by at least 30% annually and to invest wisely in growth and innovation."